Abacus Bioscience
Seattle, WA
Abacus Bioscience is developing a new class of immunotherapy that unleashes the power of a novel CD180 platform technology. Our Antigen-Specific Immune Accelerants (ASIA) are POTENT, SPECIFIC and DURABLE, with broad applications across infectious disease and oncology.
abacusbioscience.comCompany Details
Founded
- 2017
Employees
- Between 2 - 10 employees
Raised
- $4,413,591
Headquarters Location
- Seattle, WA
Public
- No
Acquired
- No
CEO
- N/A
Founders
- Craig Philips
Company Collections
These are collections Abacus Bioscience is a part of. Click on the collection name to view similar companies.